Strengthening
Trials and
Research for Rheumatic
Heart Disease
Rheumatic heart disease (RHD) remains a deeply neglected disease of poverty, marked by major gaps in prevention, treatment, and access to quality health care. More than 50 million people worldwide live with RHD, most in low- and middle-income countries across Africa and Asia, where patients often present with advanced or end-stage disease.
Although global research on RHD has increased over the past two decades, there is still a critical lack of applied research and evidence-based interventions that meaningfully improve outcomes for affected communities.
Build sustainable, locally led clinical trial capacity in RHD-endemic countries, ensuring that advances in prevention and treatment have equitable reach
Collectively, the leadership team has nearly two decades of experience designing and delivering large multi-country clinical trials across low- and middle-income countries.
Paediatric Cardiologist and Specialist Scientist
Adult Cardiologist and Clinical Trial Specialist
Evidence-Based Healthcare and Training Specialist
Epidemiologist and Clinical Trial Specialist
Adult Cardiologist and Specialist Scientist
Project Manager
Research Officer
Senior Research Administrator
